Melanoma (skin) Trials in New York, United States
Conditions / Melanoma (skin) / New York, United States
Research into Melanoma (skin) spans multiple therapeutic approaches and trial phases.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05432193 | FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) | TERMINATED | PHASE1 |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | COMPLETED | PHASE1 |
| NCT00003911 | S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases | TERMINATED | PHASE2 |
| NCT00003027 | Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma | COMPLETED | PHASE3 |
| NCT00003828 | S9804: Vinorelbine in Treating Patients With Stage IV Melanoma | COMPLETED | PHASE2 |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | COMPLETED | PHASE1 |
| NCT00026520 | Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma | COMPLETED | PHASE2 |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | COMPLETED | PHASE1 |
| NCT04410445 | Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence | TERMINATED | PHASE3 |
| NCT00445965 | Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer | COMPLETED | PHASE2 |